Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (Remission Induction by Remicade in RA) study - Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalInternational Journal of Advances in Rheumatology
Volume8
Issue number4
StatePublished - Dec 1 2010

ASJC Scopus subject areas

  • Rheumatology

Cite this